TheProfitWatch

MYNZ - Mainz Biomed N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.05 -0.06 (-5.63%) --- --- -0.01 (-0.88%) 0.0 (0.21%) -0.08 (-7.39%) 0.01 (0.96%) 0.0 (0.21%)

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Category: /stock/categories/na
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
33.21
VWAP:
0.99
RVol:

Events

Period Kind Movement Occurred At

Related News